Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

02.10.2020 back forward

Another Clinical Trial Approved

Elektromikroskope picture of SARS-CoV-2  (Source: www.niaid.nih.gov)

The Paul-Ehrlich-Institut approves another phase I clinical trial for a COVID-19 vaccine candidate in Germany. This vector vaccine was developed by the German Centre for Infection Research (DZIF) and IDT Biologika.